Capralogics Inc.

Hardwick, MA

UEI
C1AJXN3ARJJ3
CAGE
5MUR2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
235 Czesky Rd, Gilbertville, MA 01031, USA
Website
capralogics.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$3,000
FY2025 $0
FY2024 $3,000
FY2023 $177,185

Contract awards

Similar vendors

About the company

Capralogics Inc. is a full service polyclonal antibody production facility that has been dedicated to providing high quality animal serum and PBMCs to the diagnostic, pharmaceutical and research industries for over 29 years. Capralogics Inc. is a for-profit corporate entity and manufacturer of goods registered in the System for Award Management to receive federal contracts and grants.

Capralogics Inc. has received several prime contract awards from the Department of Health and Human Services' National Institutes of Health (NIH) to conduct immunization studies and provide testing services. In August 2023, NIH's National Institute of Allergy and Infectious Diseases awarded Capralogics a $198,570 purchase order to immunize alpacas with HIV-1 envelope trimers, collect blood samples, isolate and store peripheral blood mononuclear cells, and ship samples to develop broadly neutralizing nanobodies targeting the virus' CD4 binding site. This non-competitive award continues previous studies begun in 2007. The National Cancer Institute also issued Capralogics a $16,265 firm-fixed-price purchase order in July 2023 for testing services supporting the agency's cancer research mission. In January 2021, during the COVID-19 pandemic, NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases contracted with Capralogics for $11,315 to provide llama injection, maintenance, and sample shipping services to aid coronavirus research efforts. No subcontractors or set-aside designations were identified across these prime contract awards to the for-profit manufacturer focused on animal-based antibody development and testing.

Quick answers

Is Capralogics Inc. registered in SAM.gov?

Yes. Capralogics Inc.'s SAM.gov registration is active through December 1, 2026.

What is Capralogics Inc.'s CAGE code?

Capralogics Inc.'s CAGE code is 5MUR2, and its Unique Entity ID (UEI) is C1AJXN3ARJJ3.

How much has Capralogics Inc. received in federal contracts?

Federal contracts obligated $177,185 to Capralogics Inc. in fiscal years 2023 through 2027.

What is Capralogics Inc.'s most recent federal award?

Capralogics Inc.'s most recent federal contract award is Immunization of alpacas with HIV 1 ENV trimers to develop broadly neutralizing nanobodies targeting CD4 biding site (75N93023P01111), from National Institute of Allergy and Infectious Diseases (NIH), on August 25, 2023.

On GovTribe

See Capralogics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe